Please use this identifier to cite or link to this item:
Title: Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes Mellitus.
Austin Authors: Biswas, Sinjini;Dinh, Diem;Andrianopoulos, Nick;Lefkovits, Jeffrey;Ajani, Andrew;Duffy, Stephen J;Chan, William;Walton, Antony;Brennan, Angela;Clark, David J ;Hiew, Chin;Oqueli, Ernesto;Reid, Christopher M;Stub, Dion;Eccleston, David
Affiliation: School of Public Health, Curtin University, Perth, Australia
Department of Cardiology, Ballarat Health Services, Ballarat, Australia
School of Medicine, Deakin University, Ballarat, Australia
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Department of Cardiology, The Alfred Hospital, Melbourne, Australia
Department of Cardiology, University Hospital Geelong, Geelong, Australia
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
Department of Medicine, University of Melbourne, Melbourne, Australia
Baker Heart and Diabetes Institute, Melbourne, Australia
Issue Date: 1-Jun-2021
Date: 2021-03-03
Publication information: The American Journal of Cardiology 2021; 148: 36-43
Abstract: There are conflicting data on whether patients with insulin-treated diabetes mellitus (ITDM) have poorer outcomes compared with non-insulin treated diabetic (non-ITDM) patients following percutaneous coronary intervention (PCI). We therefore compared clinical outcomes following PCI in ITDM versus non-ITDM patients. We prospectively collected data on 4,579 patients with diabetes underwent PCI between 2005 and 2014 in a large multicenter registry and dichotomized them as having ITDM (n = 1,111) or non-ITDM (n = 3,468). The non-ITDM group was further divided into diet control only (diet-DM; n = 786) and those taking oral hypoglycemic agents (OHG-DM; n = 2,639), and clinical outcomes were compared with ITDM patients. Median follow-up for long-term mortality was 4.2 years (IQR 2.0 to 6.6 years). ITDM patients were more likely to be female, obese, and have severe renal impairment (all p <0.001). Procedural characteristics were similar other than a greater use of drug-eluting stents in ITDM patients. On multivariable analysis, ITDM was an independent predictor of 12-month major adverse cardiovascular and cerebrovascular events (MACCE; OR 1.26, 95% CI 1.02 to1.55, p = 0.03). Dividing the non-ITDM group further by treatment, a progressively higher rate of 12-month MACCE across the 3 groups was observed (13.5% vs 17.9% vs 21.8%; p <0.001). Long-term mortality was similar in the diet-DM and OHG-DM groups, but significantly higher in the ITDM group on Kaplan-Meier analysis (log-rank p <0.001). In conclusion, there is a clear gradient of adverse outcomes with escalation of therapy from diet control to OHGs to insulin.
DOI: 10.1016/j.amjcard.2021.02.025
Journal: The American Journal of Cardiology
PubMed URL: 33667454
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on May 27, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.